Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • Breakthrough Discoveries
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      John N. Weinstein Image

      John N. Weinstein, MD, PhD

      Department of Bioinformatics and Computational Biology, Division of Discovery Science

      Present Title & Affiliation

      Primary Appointment

      Professor, Bioinformatics & Comp Biology, Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Endowed Distinguished Chair Hubert L. Stringer Chair in Cancer Research, Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor (Joint appointment), Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1971Harvard Medical School, Boston, Massachusetts, US, MD
      1971Harvard University, Cambridge, Massachusetts, US, Ph.D. in Biophysics
      1964Harvard University, Cambridge, Massachusetts, US, BA in Biology

      Postgraduate Training

      1972-1973Residency in Medicine, Stanford University Medical Center, Stanford, California
      1971-1972Internship in Medicine, Stanford University Medical Center, Stanford, California

      Licenses & Certifications

      1973California State Medical License

      Experience & Service

      Extramural Institutional Committee Activities

      Chair, Community of Science Chairs, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Vice-Chair, Community of Science Chairs, The University of Texas MD Anderson Cancer Center, 2021 - 2022

      Advisor, Single-Cell Sequencing Core, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Advisory Board, Metabolomics Core, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Lead Co-Chair, The Data Science Forum (in association with the newly forming Institute for Data Science in Oncology (2023-present), The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, RAI Committee (evaluating major institutional informatics projects), The University of Texas MD Anderson Cancer Center, 2021 - Present

      Advisor, RPPA Core and Metabolomics Core, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Co-Chair, Research Leadership Team (RLT) Data Management Working Team, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, D3CODE, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Co-Chair (with David Jaffray), Data Science and Modeling Initiative at MD Anderson, The University of Texas MD Anderson Cancer Center, 2020 - 2022

      Member, Community of Science Chairs, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Co-founder/Advisor, GSBS Single-Cell Sequencing Course, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Advisor, CPRIT Single Cell Genomics Center, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Member, Translational Research Strategic Planning Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Member, Technology Task Force, The University of Texas MD Anderson Cancer Center, 2013 - 2014

      Supervisor (co-director), UT MD Anderson CCSG Metabolomics Core Facility, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Evaluator, Chief Information Officer Recruitment, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Member, Chief Research Information Officer (CRIO) Recruitment Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Advisor, Reverse Phase Protein Array (RPPA) Core, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Member, Organizing Committee, GSBS Course, "Introduction to Bioinformatics", The University of Texas MD Anderson Cancer Center, 2012 - Present

      Member, Institutional Research Executive Committee (IREC) IT Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Chair, Institutional Research Executive Committee (IREC) Bioinformatics Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - 2012

      Member, MD Anderson Technology Task Force, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Faculty Member, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, 2009 - Present

      Member, Clinical Trials Network, The University of Texas MD Anderson Cancer Center, 2009 - Present

      Member, The Cancer Prevention Research Institute of Texas (CPRIT) Grant Planning Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present

      Member, Steering Committee of the Institute for Personalization of Cancer Therapy (IPCT), The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, Adelson Medical Research Foundation (AMRF), The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, Center for Clinical and Translational Sciences (CCTS), The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, The Gulf Coast Center for Computational Cancer Research (GCCC), The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, Research Education and Information Systems Steering Team (RE&ISST), The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, M. D. Anderson Cancer Center Executive Committee of the Science Faculty (ECSF), The University of Texas MD Anderson Cancer Center, 2008 - 2012

      Member, Biomarker-Based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE), The University of Texas MD Anderson Cancer Center, 2008 - 2011

      Member, cancer Biomedical Informatics Grid (caBIG), The University of Texas MD Anderson Cancer Center, 2008 - 2010

      Member, Ovarian Cancer Research Fund (OCRF), The University of Texas MD Anderson Cancer Center, 2008 - 2010

      Editorial Activities

      Ad Hoc Editor, Proc. Natl Acad. Sci U.S.A, 2014 - Present

      Senior Editor, Cancer Research, 2013 - 2015

      Editor, Current Cancer Drug Target, 2008 - Present

      Honors & Awards

      2023h-index raised to 135 (Scopus), with >400 publication, including 14 as first author in Science (11) and Nature (3)
      20212020 AACR Team Science Award, American Association for Cancer Research
      2020“Highly-Cited Scientist of the Decade”, Web of Science
      2017Nominee, The Break Through Prize in the Life Sciences
      2015Best Boss Award, The University of Texas MD Anderson Cancer Center
      2014Nominee, The Dan David Prize, the Dan David Foundation
      2011Nominee, Mentoring Excellence Award, The University of Texas MD Anderson Cancer Center
      2011Nominee, The Japan Prize, The Japan Prize Foundation
      2010Nominee, Bower Award and Prize for Achievement in Science
      2008Nominee, Institute of Medicine of the National Academy of Sciences
      2006Undergraduate Scholarship Program Recognition Award, National Institutes of Health
      2006NCI Director's Innovation Award, National Cancer Institute
      2006Technology Transfer Award
      2005CLAS Distinguished Scientist Award
      2004Nominee, National Medal of Technology
      2002General Motors Lecturer
      1999Public Health Service Meritorious Service Medal
      1998NCI Intramural Research Award, NCI
      1996NIH Commendation Medal, NIH
      1995 - 1997Equal Employment Opportunity Officer's Awards
      1988Public Health Service Outstanding Service Medal
      1987Creasy Memorial Lectureship, Sloan-Kettering and Cornell Medical School
      1960 - 1964Honorary National Scholarship
      1960 - 1961Harvard College Scholarship

      Professional Memberships

      American Association for the Advancement of Science

      2022 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2008. Computational Biology Working Group. Conference. Computational Biology Working Group. Austin, TX, US.

      National Presentations

      1. 2016. Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project. Conference. Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project. New Orleans, LA, US.
      2. 2016. Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project. Conference. AACR. New Orleans, LA, US.
      3. 2012. TCGA 2nd Annual Symposium. Conference. TCGA 2nd Annual Symposium. Crystal City, VA, US.
      4. 2012. TCGA PAN-Cancer Workshop. Conference. TCGA PAN-Cancer Workshop. Santa Cruz, CA, US.
      5. 2012. American Association for Cancer Research. Conference. American Association for Cancer Research. Chicago, IL, US.
      6. 2011. Personalizing Cancer Medicine: Bioinformatics and the Omic Revolution. Conference. IEEE - GENSIPS’11. San Antonio, TX, US.
      7. 2011. The Cancer Genome Atlas (TCGA). Conference. The Cancer Genome Atlas (TCGA). National Harbor, MD, US.
      8. 2011. 7th EDRN Scientific Meeting. Conference. 7th EDRN Scientific Meeting. Bethesda, MD, US.
      9. 2011. TCGA with Respect to Informatics and Biomarkers. Conference. TCGA with Respect to Informatics and Biomarkers. Bethesda, MD, US.
      10. 2011. Batch Effects. Conference. The Cancer Genome Atlas (TCGA). North Bethesda, MD, US.
      11. 2011. American Association for Cancer Research. Conference. American Association for Cancer Research. Orlando, FL, US.
      12. 2010. Analyzing TCGA Data: A novel, systems-oriented method for diagnosing batch effects and adjusting for them. Conference. American Association for Cancer Research. Washington, DC, US.
      13. 2009. Bioinformatics and personalization of cancer management: the data tsunami. Conference. Frontiers of Cancer Research: Biology, Emerging Technologies and Therapeutics. Houston, TX, US.
      14. 2009. The Future of Genomic Medicine II. Conference. The Future of Genomic Medicine II. La Jolla, CA, US.
      15. 2008. High Performance Computing in the 'Personalization' of Cancer Therapy: Genomics, Proteomics, and Bioinformatics. Conference. Supercomputing Conference 08. Austin, TX, US.
      16. 2008. An Integromic Approach to Drug and Biomarker Discovery. Conference. 61st Annual Symposium on Cancer Research on Systems Biology. Houston, TX, US.

      International Presentations

      1. 2010. American Association for Cancer Research. Conference. American Association for Cancer Research. Amsterdam, NL.
      2. 2009. Personalizing Cancer Medicine: The Bioinformatic Challenge of Data Integration. Conference. Personalizing Cancer Medicine: The Bioinformatic Challenge of Data Integration. Beijing, CN.
      3. 2009. Personalizing cancer therapy: pharmacogenomics, pharmacoproteomics, and pharmacoinformatics. Conference. Frontiers of Pharmaceutical Sciences. Toronto, CA.
      4. 2008. Omix molecular profiling and bioinformatics in the personalization of medicine. Conference. 2008 Annual OMIX Symposium. Tokyo, JP.
      5. 2008. How Systems Biology can advance Cancer Research. Conference. How Systems Biology can advance Cancer Research. Bruxelles, BE.

      Formal Peers

      1. 2017. Rigor and Reproducibility Workshop. Invited, TX, US.
      2. 2013. SouthWest Oncology Group (SWOG). Invited. Chicago, IL, US.
      3. 2013. SouthWest Oncology Group. Invited. San Francisco, CA, US.
      4. 2012. RapTOR External Advisory Board. Invited. Livermore, CA, US.
      5. 2012. "Omics and Integration in Biology and Medicine. Invited. Bethesda, MD, US.
      6. 2012. USC-PSOC and ASU-CASI Workshop. Invited. Scottsdale, AZ, US.
      7. 2011. 7th EDRN Scientific Meeting. Invited. Bethesda, MD, US.
      8. 2011. Translational Science Meeting 2011: From Molecular Information to Cancer Medicine. Invited. Washington, DC, US.
      9. 2011. The University of California at San Francisco SPORE Meeting. Invited. San Francisco, CA, US.
      10. 2011. The Cancer Genome Atlas (TCGA) Lung Analysis Workshop Group Meeting. Invited. Chapel Hill, NC, US.
      11. 2011. Computational Biology and Bioinformatics. Invited. College Station, TX, US.
      12. 2011. The Cancer Genome Atlas (TCGA) Steering Committee Meeting. Invited. Bethesda, MD, US.
      13. 2011. Bioinformatics in the Personalization of Cancer Medicine. Invited. St. Louis, MO, US.
      14. 2010. The Cancer Genome Atlas (TCGA) Steering Committee Meeting. Invited. Long Beach, CA, US.
      15. 2010. Hematology Oncology. Invited. Baltimore, MD, US.
      16. 2010. The Cancer Genome Atlas (TCGA) Steering Committee Meeting. Invited. Bethesda, MD, US.
      17. 2010. Bioinformatics and Systems Biology Analysis of high-throughput data; identification of biomarkers for cancer risk and outcome using a systems biology approach; available tools and programs. Invited. Houston, TX, US.
      18. 2009. TCGA Ovarian Cancer Workshop. Invited. Berkeley, CA, US.
      19. 2009. Cancer & Cell Biology Division Annual Retreat. Invited. Phoenix, AZ, US.
      20. 2008. The Cancer Genome Atlas Steering Committee Meeting. Invited. Bethesda, MD, US.
      21. 2008. Personalizing cancer therapy: Genomics, proteomics, and bioinformatics. Invited. Tokyo, JP.
      22. 2008. Personalizing cancer therapy: Integrative genomics, proteomics, and bioinformatics. Invited. Washington, DC, US.
      23. 2008. The Cancer Genome Atlas Pilot Project Steering Committee Meeting. Invited. New York, NY, US.
      24. 2008. Developing the tools and Technologies To Move From Data to Knowledge. Invited. Columbus, OH, US.
      25. 2008. High-Throughput Integromic Profiling of Cancer Cells: Genomics, Proteomics, and Bioinformatics. Invited. Orlando, FL, US.
      26. 2008. Futures Workshop on Personalized Medicine. Invited. Houston, TX, US.
      27. 2008. Integromic Analysis of Drug and Radiation Effects on Cancer Cells: Genomics, Proteomics, and Bioinformatics. Invited. Washington, DC, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - 2029
      Title:MBatch: A dynamically interactive, AI-driven computational resource for detecting and mitigating batch effects in multi-omic cancer datasets
      Funding Source:Cancer Prevention & Research Institute of Texas
      Role:Co-I
      ID:RP27035
      Date: 2026 - 2029
      Title:CancerOmicsInTexas.com (CoMiT): A Comprehensive AI/LLM/NLP-based Website and Comprehensive Information Resource on Cancer Omics Research and Researchers in Texas
      Funding Source:Cancer Prevention & Research Institute of Texas
      Role:PI
      ID:RP270199
      Date: 2024 - 2029
      Title:Enhancing Next-Generation Clustered Heat Maps, including support for the integrated analysis and visualization of multi-omic data
      Funding Source:NIH/NCI
      Role:MPI
      ID:AN:4847549
      Date: 2022 - 2027
      Title:The Cancer Proteome Atlas: An Integrated Bioinformatics Resource for Functional Cancer Proteomic Data
      Funding Source:NCI
      Role:Co-I
      ID:U24CA264128
      Date: 2022 - 2025
      Title:OmicBlender: A Web Resource for Dynamically Interactive Visual Integration of User-Generated and Public Molecular Profiling Data Sets
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:1 U01 CA 274571 - 01
      Date: 2022 - 2027
      Title:MD Anderson proteogenomic data analysis center for CPTAC
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:1 U24 CA271078-01
      Date: 2021 - 2027
      Title:A Genome Data Analysis Center Focused on Batch Effect Analysis and Data Integration
      Funding Source:NIH/NCI
      Role:MPI
      ID:U24CA264006
      Date: 2021 - 2026
      Title:A Web Resource for Dynamically Interactive Visual Integration of User-Generated and Public Molecular Profiling Data Sets
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:R01 CA266333
      Date: 2021 - 2026
      Title:Mouse models of leukemia
      Funding Source:NIH/NCI
      Role:PI
      ID:1R01 CA25250-01
      Date: 2021 - 2021
      Title:An Advanced Next-Generation Clustered Heat Map System for Visualization and Analysis of Large Omic Datasets, with a Version Customized
      Funding Source:NIH/NCI
      Role:Multi PI
      ID:U24 CA253371
      Date: 2020 - 2026
      Title:Characterization and modeling of m6A RNA methylation in cancer
      Funding Source:NCI
      Role:Co-I
      ID:R01CA251150
      Date: 2020 - 2025
      Title:Deciphering Functional Consequences of Specific and Combinatorial Mutations in Protein Interaction Networks
      Funding Source:NIH/NCI
      Role:OSC
      ID:5 R35GM137836-04
      Date: 2020 - 2023
      Title:Combination of immuno- and targeted therapies guided by multi-omics characterization of the TP53 pathway, TGF-beta and stromal signature in breast cancer
      Funding Source:DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
      Role:CO-I
      ID:BC200871
      Date: 2020 - 2025
      Title:Informatics for Cancer Research Education and Training (iCREAT)
      Funding Source:NIH via UT Health Science
      Role:Principal Investigator-MDACC
      ID:FP9999
      Date: 2020 - 2025
      Title:An Advanced Next-Generation Clustered Heat Map System for Visualization and Analysis of Large Omic Datasets, with a Version Customized for Single-Cell Sequencing Data
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:U24 CA253371
      Date: 2020 - 2025
      Title:Identification of Clinically Relevant Genomic Signatures of Lethal Variants of Bladder Cancer
      Funding Source:NIH/NCI
      Role:Collaborator
      ID:R01 CA247657
      Date: 2020 - 2025
      Title:Bladder Cancer Evolution from Field Effects by Whole-Organ Mapping
      Funding Source:NIH/NCI
      Role:Collaborator
      ID:R01 CA247866
      Date: 2019 - 2024
      Title:Integrating Theory with Experiment to Discover Biomolecular Mechanisms
      Funding Source:Sandia National Laboratories (Subaward via NIH)
      Role:Principal Investigator-MDACC
      Date: 2019 - 2026
      Title:Cancer Center Support Grant - Biostatistics Shared Resource (Bioinformatics Resource Group)
      Funding Source:NIH/NCI
      Role:Core Leader
      ID:P30CA016672
      Date: 2019 - 2024
      Title:CCSG (CORE) ProgInc -Developing SR-Metabolomics
      Funding Source:NIH/NCI
      Role:CO-I
      ID:P30CA016672
      Date: 2019 - 2024
      Title:MBatch: A highly interactive computational resource for detecting, diagnosing, visualizing, interpreting, and correcting batch and trend effects in cancer molecular profiling data
      Funding Source:NIH/NCI
      Role:PI
      Date: 2019 - 2022
      Title:Toward curative therapy for hematologic diseases by metronomic administration of L-asparaginase
      Funding Source:Leukemia and Lymphoma Society
      Role:PI
      Date: 2018 - 2022
      Title:Computational Tools for Analysis and Visualization of Quality Control Issues in Metabolomic Data
      Funding Source:NIH/NCI
      Role:PI
      ID:5 U01 CA235510 - 05
      Date: 2018 - 2023
      Title:Multidimensional Mapping of the path from polyp to cancer: a chapter in the PreCancer Atlas
      Funding Source:Mayo Clinic (Subaward via NIH)
      Role:CO-I
      Date: 2017 - 2021
      Title:Reaction Mechanism in Therapeutic Asparaginases: Re-designing Enzymes for Faster Catalysis and Customized Selectivity
      Funding Source:Sandia National Laboratories (Subaward with NIH)
      Role:MDACC PI
      Date: 2017 - 2019
      Title:Development of L-asparaginase Analogs with Improved Therapeutic Index
      Funding Source:ALEX'S LEMONADE STAND FOUNDATION
      Role:PI
      ID:FP00001724
      Date: 2017 - 2019
      Title:Defining roles for leukemia inhibitory factor in dendritic cell development and function
      Funding Source:NIH/NCI
      Role:Collaborator
      ID:FP00001824
      Date: 2017 - 2022
      Title:Identification of potentially targetable pathways in rare cancers by borrowing information from common cancers through the analysis of TCGA omics data
      Funding Source:NIH/NCI
      Role:CO-I
      ID:R01 CA215106
      Date: 2017 - 2018
      Title:"Next-Generation" Clustered Heat Maps for fluent, interactive exploration of omic data: IVYGAP Supplement
      Funding Source:NIH/NCI
      Role:Co-PI
      Date: 2016 - 2021
      Title:Integrated analysis of protein expression data from the Reverse Phase Protein Array (RPPA) platform
      Funding Source:NCI
      Role:Co-PI
      ID:U24 CA210950
      Date: 2016 - 2021
      Title:Batch effects in molecular profiling data on cancers: detection, quantitation, interpretation, and correction
      Funding Source:NIH/NCI
      Role:PI
      ID:U24 CA210949
      Date: 2016 - 2021
      Title:TCPA: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data
      Funding Source:NIH/NCI
      Role:CO-I
      ID:U24 CA 209851
      Date: 2016 - 2017
      Title:Genomic Data Analysis Network: Specialized Genomic Data Center (U24)
      Funding Source:NIH/NCI
      Role:PI
      ID:U24
      Date: 2016 - 2021
      Title:CPRIT MIRA Core 3- Biostatistics/Bioinformatics
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP160693 C3
      Date: 2016 - 2019
      Title:Mechanisms of carcinogenesis and therapeutic vulnerabilities associated with RBM10 loss in KRAS mutant NSCLC
      Funding Source:Department of Defense Lung Cancer Development
      Role:Collaborator
      ID:LC150174
      Date: 2016 - 2016
      Title:Integrative Pipeline for Analysis & Translational Application of TCGA Data: The University of Texas MD Anderson TCGA Genome Data Analysis Center
      Funding Source:NIH/NCI
      Role:Lead PD/PI
      ID:3 U24 CA143883 05S2
      Date: 2016 - 2016
      Title:Functional and quantitative analysis of PARP protein variants and post-translational modifications
      Funding Source:Rockland-NIH (SBIR)
      Role:CO-I
      Date: 2015 - 2021
      Title:"Next Generation" clustered Heat Maps for fluent, interactive exploration of omic data
      Funding Source:NCI
      Role:PI
      ID:U24 CA199461
      Date: 2015 - 2020
      Title:Next-Generation Clustered Heat Maps for fluent, interactive exploration of omic data
      Funding Source:NCI
      Role:PI
      ID:U24 CA199461
      Date: 2015 - 2018
      Title:Center for Analysis, Interpretation, and Visualization of Biomedical Big Data
      Funding Source:NIH/NCI
      Role:Principal Investigator-MDACC
      ID:1U54HG008069-01
      Date: 2015 - 2016
      Title:Omic Explorer: An interactive resource for collaborative visualiziation-guided discovery
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:11682986
      Date: 2014 - 2015
      Title:Development of L-asparaginase analogs with improved therapeutic index
      Funding Source:Leukemia and Lymphoma Society
      Role:PI
      Date: 2014 - 2018
      Title:Center for Analysis, Interpretation, and visualization of Biomedical Big Data
      Funding Source:NIH/NCI
      Role:Co-PI
      Date: 2013 - 2019
      Title:A Proteomics and Metabolomics Core Facility at the University of Texas MD Anderson Cancer Center
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:RP130397
      Date: 2013 - 2018
      Title:The University of Texas MD Anderson Cancer Center SPORE in Leukemia (Core C: Biostatistics, Data Management, and Bioinformatics)
      Funding Source:NIH/NCI
      Role:Core Co-Director
      ID:5P50CA100632
      Date: 2012 - 2017
      Title:Center for Clinical and Translational Research (CCTS)
      Funding Source:NIH/NCI
      Role:Collaborator - Research Informatics
      ID:4 UL1 TR000371-10
      Date: 2012 - 2017
      Title:Training of Academic Head and Neck Surgical Oncologist
      Funding Source:NIH/NCI
      Role:Faculty Mentor
      ID:2 T32 CA060374 16
      Date: 2012 - 2015
      Title:CyTof Mass Cytometer and Element Tagging System
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:TO BE DETERMINED
      ID:RFA R-12-SIA-1
      Date: 2011 - 2016
      Title:The Cancer Reclassification Project
      Funding Source:NIH/NCI
      Role:PI
      ID:1 R01 CA163260 01
      Date: 2011 - 2016
      Title:CPRIT Proteomics Center: Biomarker and Target Discovery Core 2: Informatics and Systems Biology and Biostatistics
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Core Leader
      ID:RP110694
      Date: 2011 - 2016
      Title:CyTOF Mass Cytometer and Element Tagging System
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP110775
      Date: 2011 - 2021
      Title:The Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine
      Funding Source:Michael and Susan Dell Foundation
      Role:PI
      ID:CV11121361
      Date: 2011 - 2016
      Title:Integrated Multi-Analytic Molecular Signatures In Acute Myelogenous Leukemia
      Funding Source:NIH/NCI
      Role:Investigator
      ID:1 U01 CA157711 01
      Date: 2011 - 2016
      Title:BATTLE-2: Personalizing Non-Small Cell Lung Cancer Therapy
      Funding Source:NIH/NCI
      Role:Co-Core Director
      ID:1 P01 CA148133 01A1
      Date: 2011 - 2015
      Title:Expression and evolution of young duplicate genes in the human genome
      Funding Source:NIH/NIGMS
      Role:CO-I
      ID:1 R01 GM097266 01
      Date: 2010 - 2015
      Title:Metabolic and Molecular Targets for Breaking the Obesity-Cancer Link: Fuel for Future Interventions
      Funding Source:NIH (Subcontract from the University of Texas, Austin)
      Role:CO-I
      Date: 2010 - 2015
      Title:Institutional Clinical and Translational Science Award (U54)
      Funding Source:NIH/NCRR (Subcontract from The University of Texas Health Science Center)
      Role:CO-I
      ID:2 UL1 RR024148 05
      Date: 2010 - 2013
      Title:Comprehensive Analysis of Genetic and Epigenetic Changes in Oral Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP100233-02
      Date: 2010 - 2015
      Title:CPRIT Proteomics Center: Biomarker and Target Discovery (PC-D)
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Core Leader
      Date: 2010 - 2015
      Title:CPRIT Proteomics Center: Biomarker and Target Discovery (PP-1)
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Project Leader
      Date: 2010 - 2015
      Title:Genomic, Epigenomic, and Transcriptome Profile of Bladder Cancer Development
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-Core Leader
      ID:RP101298
      Date: 2010 - 2015
      Title:CPRIT Proteomics Center: Biomarker and Target Discovery (PC-C)
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Core Leader
      Date: 2010 - 2015
      Title:Biomarker Development for Acute Myelogenous Leukemia with Complex Karyotype
      Funding Source:NIH/NCI
      Role:Significant Contributor
      ID:1 UO1 CA152812 01
      Date: 2010 - 2015
      Title:New Approaches to the Biology and Treatment of Myelodysplastic Syndrome (MDS) (PC-C)
      Funding Source:NIH/NCI
      Role:Co-Core Director
      ID:2 P01 CA108631 06
      Date: 2010 - 2021
      Title:Philanthropic Funds
      Funding Source:Mary K. Chapman Foundation
      Role:PI
      ID:80-107216-19
      Date: 2009 - 2014
      Title:p53 regulates ER alpha expression in breast cancer cells: prognostic and therapeutic implications
      Funding Source:NIH/NCI
      Role:Collaborator
      ID:1 R01 CA143423 01
      Date: 2009 - 2014
      Title:Genomic, Epigenomic, and Transcriptome Profile of Bladder Cancer Development
      Funding Source:NIH/NCI
      Role:Core Co-Director
      ID:1 P01 CA142567 01
      Date: 2009 - 2011
      Title:The Cancer Metabolome: a study of similarities and differences
      Funding Source:NIH/NCI (Subcontract from University of Michigan)
      Role:Principal Investigator-MDACC
      ID:RFA-OD-09-003
      Date: 2009 - 2011
      Title:Novel Forms of Clustered Heat Maps for Pattern Recognition in Omic Data
      Funding Source:NIH/NCI
      Role:PI
      ID:1 RC1 CA145800 01
      Date: 2009 - 2011
      Title:Biomarkers for Personalized Cancer Therapy
      Funding Source:NIH/NCI
      Role:CO-I
      ID:1 RC2 CA148020 01
      Date: 2009 - 2015
      Title:An Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)
      Funding Source:NIH/NCI
      Role:PI
      ID:5 U24 CA143883 04
      Date: 2009 - 2012
      Title:ARRA: An Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC) - Admin Supplement
      Funding Source:NIH/NCI
      Role:PI
      ID:3 U24 CA143883 02S1
      Date: 2009 - 2012
      Title:Comprehensive Analysis of Genetic Alterations in Oral Cancer
      Funding Source:NIH/NIDCR
      Role:Collaborator
      ID:5 RC2 DE020958 02
      Date: 2009 - 2014
      Title:Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas (PP-1)
      Funding Source:NIH/NIDCR
      Role:Co-Project Leader
      ID:5 U01 DE019765 05
      Date: 2009 - 2011
      Title:The effect of biospecimen handling, shipping, storage and time on microRNA, protein, and serum stability and array results
      Funding Source:NIH/NCI
      Role:CO-I
      ID:1 RC1 CA147862 01
      Date: 2009 - 2011
      Title:Development of multi-disciplinary center for molecular targets and signaling networks
      Funding Source:NIH/NCI
      Role:Subproject Leader
      ID:1 RC2 CA148333 01
      Date: 2009 - 2011
      Title:The Acute Myelogenous Leukemia Integromics Atlas
      Funding Source:NIH/NCI
      Role:CO-I
      ID:1 RC2 CA148419 01
      Date: 2009 - 2012
      Title:Autophagy in Ovarian Cancer: Molecular Analysis Core (PC-A)
      Funding Source:Ovarian Cancer Research Fund
      Role:Core Director
      ID:PPD/MDACC/01.08 03
      Date: 2008 - 2013
      Title:Mapping the epigenome of human hematopoietic cells
      Funding Source:NIH/NIEHS
      Role:CO-I
      ID:1 U01 ES017157 01
      Date: 2008 - 2011
      Title:Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination - AKA Battle II (PC-J)
      Funding Source:Cohen-Reinach Family Charitable Foundation
      Role:Collaborator
      Date: 2000 - 2003
      Title:Design, Development, and Programming Support for National Cancer Institute's Laboratory of Molecular Pharmacology Bioinformatics Projects
      Funding Source:NIH/NCI
      Role:PI
      ID:NCI Delivery Order 48
      Date: 1999 - 2010
      Title:The University of Texas M. D. Anderson SPORE in Ovarian Cancer (PP-DPR-16)
      Funding Source:NIH/NCI
      Role:Project Leader
      ID:5 P50 CA083639 10
      Title:Lung SPORE: Targeting Lung Cancer Vulnerabilities
      Funding Source:UTMDACC
      Role:Internal Scientific Advisory Board

      Selected Publications

      Peer-Reviewed Articles

      1. Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RI, Lin Z, Feuerbach L, Sabarinathan R, Madsen T, Kim J, Mularoni L, Shuai S, Lanzós A, Herrmann C, Maruvka YE, Shen C, Amin SB, Bandopadhayay P, Bertl J, Boroevich KA, Busanovich J, Carlevaro-Fita J, Chakravarty D, Chan CWY, Craft D, Dhingra P, Diamanti K, Fonseca NA, Gonzalez-Perez A, Guo Q, Hamilton MP, Haradhvala NJ, Hong C, Isaev K, Johnson TA, Juul M, Kahles A, Kahraman A, Kim Y, Komorowski J, Kumar K, Kumar S, Lee D, Lehmann KV, Li Y, Liu EM, Lochovsky L, Park K, Pich O, Roberts ND, Saksena G, Schumacher SE, Sidiropoulos N, Sieverling L, Sinnott-Armstrong N, Stewart C, Tamborero D, Tubio JMC, Umer HM, Uusküla-Reimand L, Wadelius C, Wadi L, Yao X, Zhang CZ, Zhang J, Haber JE, Hobolth A, Imielinski M, Kellis M, Lawrence MS, von Mering C, Nakagawa H, Raphael BJ, Rubin MA, Sander C, Stein LD, Stuart JM, Tsunoda T, Wheeler DA, Johnson R, Reimand J, Gerstein M, Khurana E, Campbell PJ, López-Bigas N, Working Group PDAFI, Working Group PSV, Weischenfeldt J, Beroukhim R, Martincorena I, Pedersen JS, Getz G, Consortium P. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578(7793):102-111, 2020. e-Pub 2020. PMID: 32025015.
      2. Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD, Working Group PE&H, Spellman PT, Wedge DC, Van Loo P, Consortium P. The evolutionary history of 2,658 cancers. Nature 578(7793):122-128, 2020. e-Pub 2020. PMID: 32025013.
      3. Li Y, Roberts ND, Wala JA, Shapira O, Schumacher SE, Kumar K, Khurana E, Waszak S, Korbel JO, Haber JE, Imielinski M, Working Group PSV, Weischenfeldt J, Beroukhim R, Campbell PJ, Consortium P. Patterns of somatic structural variation in human cancer genomes. Nature 578(7793):112-121, 2020. e-Pub 2020. PMID: 32025012.
      4. Core Group PT, Calabrese C, Davidson NR, Demircioglu D, Fonseca NA, He Y, Kahles A, Lehmann KV, Liu F, Shiraishi Y, Soulette CM, Urban L, Greger L, Li S, Liu D, Perry MD, Xiang Q, Zhang F, Zhang J, Bailey P, Erkek S, Hoadley KA, Hou Y, Huska MR, Kilpinen H, Korbel JO, Marin MG, Markowski J, Nandi T, Pan-Hammarström Q, Pedamallu CS, Siebert R, Stark SG, Su H, Tan P, Waszak SM, Yung C, Zhu S, Awadalla P, Creighton CJ, Meyerson M, Ouellette BFF, Wu K, Yang H, Working Group PT, Brazma A, Brooks AN, Göke J, Rätsch G, Schwarz RF, Stegle O, Zhang Z, Consortium P. Genomic basis for RNA alterations in cancer. Nature 578(7793):129-136, 2020. e-Pub 2020. PMID: 32025019.
      5. Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN, Islam SMA, Lopez-Bigas N, Klimczak LJ, McPherson JR, Morganella S, Sabarinathan R, Wheeler DA, Mustonen V, Working Group PMS, Getz G, Rozen SG, Stratton MR, Consortium P. The repertoire of mutational signatures in human cancer. Nature 578(7793):94-101, 2020. e-Pub 2020. PMID: 32025018.
      6. Genomes Consortium IPAOW. Pan-Cancer analysis of whole genomes. Nature 578(7793):82-93, 2020. e-Pub 2020. PMID: 32025007.
      7. Wang F, Zhang S, Kim TB, Lin YY, Iqbal R, Wang Z, Mohanty V, Sircar K, Karam JA, Wendl MC, Meric-Bernstam F, Weinstein JN, Ding L, Mills GB, Chen K. Integrated transcriptomic-genomic tool Texomer profiles cancer tissues. Nat Methods 16(5):401-404, 2019. e-Pub 2019. PMID: 30988467.
      8. Corces MR, Granja JM, Shams S, Louie BH, Seoane JA, Zhou W, Silva TC, Groeneveld C, Wong CK, Cho SW, Satpathy AT, Mumbach MR, Hoadley KA, Robertson AG, Sheffield NC, Felau I, Castro MAA, Berman BP, Staudt LM, Zenklusen JC, Laird PW, Curtis C, Analysis Network CGA, Greenleaf WJ, Chang HY. The chromatin accessibility landscape of primary human cancers. Science 362(6413), 2018. e-Pub 2018. PMID: 30361341.
      9. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Network TR, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 174(4):1033, 2018. e-Pub 2018. PMID: 30096301.
      10. Kahles A, Lehmann KV, Toussaint NC, Hüser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Research Network CGA, Rätsch G. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Cancer Cell 34(2):211-224.e6, 2018. e-Pub 2018. PMID: 30078747.
      11. Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, Weinstein JN) CGARN(, Xie W, Yang D. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell 33(4):706-720.e9, 2018. e-Pub 2018. PMID: 29622465.
      12. Ding L, Bailey MH, Porta-Pardo E, Thorsson V, Colaprico A, Bertrand D, Gibbs DL, Weerasinghe A, Huang KL, Tokheim C, Cortés-Ciriano I, Jayasinghe R, Chen F, Yu L, Sun S, Olsen C, Kim J, Taylor AM, Cherniack AD, Akbani R, Suphavilai C, Nagarajan N, Stuart JM, Mills GB, Wyczalkowski MA, Vincent BG, Hutter CM, Zenklusen JC, Hoadley KA, Wendl MC, Shmulevich L, Lazar AJ, Wheeler DA, Getz G, Weinstein JN) CGARN(. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell 173(2):305-320.e10, 2018. e-Pub 2018. PMID: 29625049.
      13. Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Weinstein JN) CGARN(, Thorsson V, Bass AJ, Laird PW. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 33(4):721-735.e8, 2018. e-Pub 2018. PMID: 29622466.
      14. Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang LB, Zhou DC, Liu D, Cao S, Kim YW, Koire A, McMichael JF, Hucthagowder V, Kim TB, Hahn A, Wang C, McLellan MD, Al-Mulla F, Johnson KJ, Weinstein JN) CGARN(, Lichtarge O, Boutros PC, Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dipersio JF, Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell 173(2):355-370.e14, 2018. e-Pub 2018. PMID: 29625052.
      15. Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, Weinstein JN) CGAN(, Stuart JM, Benz CC, Laird PW. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173(2):291-304.e6, 2018. e-Pub 2018. PMID: 29625048.
      16. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Weinstein JN) CGARN(, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173(2):321-337.e10, 2018. e-Pub 2018. PMID: 29625050.
      17. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, Group MW, Cancer Genome Atlas Research Network (including Weinstein JN, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173(2):371-385.e18, 2018. e-Pub 2018. PMID: 29625053.
      18. Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, Weinstein JN) CGARN(, Hu H. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173(2):400-416.e11, 2018. e-Pub 2018. PMID: 29625055.
      19. Chen H, Li C, Peng X, Zhou Z, Weinstein JN, Research Network CGA, Liang H. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Cell 173(2):386-399.e12, 2018. e-Pub 2018. PMID: 29625054.
      20. Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kaminska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwinska P, Mazurek S, Mishra L, Heyn H, Krasnitz A, Godwin AK, Lazar AJ, Research Network CGA, Stuart JM, Hoadley KA, Laird PW, Noushmehr H, Wiznerowicz M. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173(2):338-54, 2018. e-Pub 2018. PMID: 29625051.
      21. Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, Schumacher SE, Wang C, Hu H, Liu J, Lazar AJ, Weinstein JN) CGARN(, Cherniack AD, Beroukhim R, Meyerson M. Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell 33(4):676-689.e3, 2018. e-Pub 2018. PMID: 29622463.
      22. Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, Research Network CGA, Weinstein JN, Mills GB, Levine DA, Akbani R. A comprehensive Pan-Cancer molecular study of gynecologic and breast cancers. Cancer Cell 33(4):690-705.e9, 2018. e-Pub 2018. PMID: 29622464.
      23. Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, Leiserson MDM, Sethi G, Lu C, Ryan M, Su X, Cherniack AD, Robertson G, Akbani R, Spellman P, Weinstein JN, Hayes DN, Raphael B, Lichtenberg T, Leraas K, Zenklusen JC, Atlas Network CG, Fujimoto J, Scapulatempo-Neto C, Moreira AL, Hwang D, Huang J, Marino M, Korst R, Giaccone G, Gokmen-Polar Y, Badve S, Rajan A, Ströbel P, Girard N, Tsao MS, Marx A, Tsao AS, Loehrer PJ. The integrated genomic landscape of thymic epithelial tumors. Cancer Cell 33(2):244-58, 2018. e-Pub 2018. PMID: 29438696.
      24. Weinstein JN) CGARN(. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell 171(4):950-965.e28, 2017. e-Pub 2017. PMID: 29100075.
      25. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Network TR, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171(3):540-556.e25, 2017. e-Pub 2017. PMID: 28988769.
      26. Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O, Akbani R, Bristow CA, Hoadley KA, Iype L, Chang MT, TCGA Research Network (including Weinstein JN, Cherniack AD, Benz C, Mills GB, Verhaak RGW, Griewank KG, Felau I, Zenklusen JC, Gershenwald JE, Schoenfield L, Lazar AJ, Abdel-Rahman MH, Roman-Roman S, Stern MH, Cebulla CM, Williams MD, Jager MJ, Coupland SE, Esmaeli B, Kandoth C, Woodman SE. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell 32(2):204-220.e15, 2017. e-Pub 2017. PMID: 28810145.
      27. address: wheeler@bcmedu CGARNE, Weinstein JN) CGARN(. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell 169(7):1327-1341.e23, 2017. e-Pub 2017. PMID: 28622513.
      28. Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB, Research Network CGA, Weinstein JN, Zhang J, Akbani R, Levine DA. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell 31(3):411-23, 2017. e-Pub 2017. PMID: 28292439.
      29. Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS, Weinstein JN) CGARN(, Pacak K, Nathanson KL, Wilkerson MD. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell 31(2):181-193, 2017. e-Pub 2017. PMID: 28162975.
      30. Weinstein JN) CGARN(. Integrated genomic and molecular characterization of cervical cancer. Nature, 2017. e-Pub 2017. PMID: 28112728.
      31. Cancer Genome Atlas Research Network (including Weinstein JN, Asan University AWG, BC Cancer Agency BC, Women’s Hospital BA, Institute B, University B, Reserve University CW, Institute DC, University D, Cancer Centre GP, School HM, Systems Biology IF, KU Leuven KU, Clinic M, Cancer Center MSK, Institute NC, Hospital NC, University S, Alabama UO, Michigan UO, North Carolina UO, Pittsburgh UO, Rochester UO, Southern California UO, Cancer Center UOTMA, Washington UO, Research Institute VA, University V, University W, Broad Institute GSC, St Louis WUI, Cancer Agency GCCB, Institute B, School HM, Hopkins University SKCCCAJ, North Carolina UO, Epigenome Center UOSC, Cancer Center UOTMA, Research Institute VA, Broad Institute GDAC, University: B, School HM, Systems Biology IF, Cancer Center MSK, Santa Cruz UOC, Cancer Center UOTMA, Genomics Consortium BCRI, Children’s Hospital RIAN, Biologic Services TSSA, Center AM, Bioscience A, Hospital BC, BioreclamationIVT, Clinic BM, Medical School CNU, Health System CC, Cureline, University D, University E, University E, of Medicine IUS, of Moldova IOO, Consortium IG, al E. Integrated genomic characterization of oesophageal carcinoma. Nature 541(7636):169-175, 2017. e-Pub 2017. PMID: 28052061.
      32. Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MC, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA, Cancer Genome Atlas Research Network (including Weinstein JN, Hammer GD, Giordano TJ, Verhaak RG. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell 30(2):363, 2016. e-Pub 2016. PMID: 27505681.
      33. Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, Rao AA, Grifford M, Cherniack AD, Zhang H, Poisson L, Carlotti CG, Tirapelli DP, Rao A, Mikkelsen T, Lau CC, Yung WK, Rabadan R, Huse J, Brat DJ, Lehman NL, Barnholtz-Sloan JS, Zheng S, Hess K, Rao G, Meyerson M, Beroukhim R, Cooper L, Akbani R, Wrensch M, Haussler D, Aldape KD, Laird PW, Gutmann DH, Weinstein JN) TRN(, Noushmehr H, Iavarone A, Verhaak RG. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell 164(3):550-63, 2016. e-Pub 2016. PMID: 26824661.
      34. Research Network CGA, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, al E. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med 374(2):135-45, 2016. e-Pub 2016. PMID: 26536169.
      35. Zhou W, Chen T, Chong Z, Rohrdanz MA, Melott JM, Wakefield C, Zeng J, Weinstein JN, Meric-Bernstam F, Mills GB, Chen K. TransVar: a multilevel variant annotator for precision genomics. Nat Methods 12(11):1002-3, 2015. e-Pub 2015. PMID: 26513549.
      36. Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GM, Factor RE, Collins LC, Allison KH, Chen YY, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA, Weinstein JN) TRN(, Perou CM. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell 163(2):506-19, 2015. e-Pub 2015. PMID: 26451490.
      37. Skoulidis F, Byers LA, Diao L, Papadimitrakopoulou VA, Tong P, Izzo J, Behrens C, Kadara H, Parra ER, Canales JR, Zhang J, Giri U, Gudikote J, Cortez MA, Yang C, Fan Y, Peyton M, Girard L, Coombes KR, Toniatti C, Heffernan TP, Choi M, Frampton GM, Miller V, Weinstein JN, Herbst RS, Wong KK, Zhang J, Sharma P, Mills GB, Hong WK, Minna JD, Allison JP, Futreal A, Wang J, Wistuba II, Heymach JV. Co-occurring genomic alterations define major subsets of KRAS - mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov 5(8):860-77, 2015. e-Pub 2015. PMID: 26069186.
      38. Research Network CGA, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372(26):2481-98, 2015. e-Pub 2015. PMID: 26061751.
      39. Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MD, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van't Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA, Research Network CGA, Benz CC, Perou CM, Stuart JM. Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin. Cell 158(4):929-44, 2014. e-Pub 2014. PMID: 25109877.
      40. Yuan Y, Van Allen EM, Omberg L, Wagle N, Amin-Mansour A, Sokolov A, Byers LA, Xu Y, Hess KR, Diao L, Han L, Huang X, Lawrence MS, Weinstein JN, Stuart JM, Mills GB, Garraway LA, Margolin AA, Getz G, Liang H. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol 32(7):644-52, 2014. e-Pub 2014. PMID: 24952901.
      41. Weinstein JN, Lorenzi PL. Discrepancies in drug sensitivity. Nature 504(7480):381-3, 2013. e-Pub 2013. PMID: 24284624.
      42. Li J, Lu Y, Akbani R, Ju Z, Roebuck PL, Liu W, Yang JY, Broom BM, Verhaak RG, Kane DW, Wakefield C, Weinstein JN, Mills GB, Liang H. TCPA: A Resource for Cancer Functional Proteomics Data. Nat Methods 10(11):1046-7, 2013. e-Pub 2013. PMID: 24037243.
      43. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O'Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein JN, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, Network TR. The somatic genomic landscape of glioblastoma. Cell 155(2):462-77, 2013. e-Pub 2013. PMID: 24120142.
      44. Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, Zweidler-McKay PA, Wu X, El-Naggar AK, Weinstein JN, Wang J, Muzny DM, Gibbs RA, Wheeler DA, Myers JN, Frederick MJ. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 3(7):770-81, 2013. e-Pub 2013. PMID: 23619168.
      45. Cancer Genome Atlas Research Network (including Weinstein JN, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA. Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67-73, 2013. e-Pub 2013. PMID: 23636398.
      46. Weinstein JN) CGARN(. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. NEJM 368(22):2059-74, 2013. e-Pub 2013. PMID: 23634996.
      47. statistical analyses) CGAN(WJF. Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61-70, 2012. e-Pub 2012. PMID: 23000897.
      48. Research Network CGA, Hammerman PS, Hayes DN, Wilkerson MD, Schultz N, Bose R, Chu A, Collisson EA, Cope L, Creighton CJ, Getz G, Herman JG, Johnson BE, Kucherlapati R, Ladanyi M, Maher CA, Robertson G, Sander C, Shen R, Sinha R, Sivachenko A, Thomas RK, Travis WD, Tsao MS, Writing Committee) WJ(SAA, Wigle DA, Baylin SB, Govindan R, Meyerson M. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489(7417):519-25, 2012. e-Pub 2012. PMID: 22960745.
      49. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, Masrorpour F, Shen L, Liu W, Duchemann B, Tumula P, Bhardwaj V, Welsh J, Weber S, Glisson BS, Kalhor N, Wistuba II, Girard L, Lippman SM, Mills GB, Coombes KR, Weinstein JN, Minna JD, Heymach JV. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov 2(9):798-811, 2012. e-Pub 2012. PMID: 22961666.
      50. Atlas Network CG. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330-7, 2012. e-Pub 2012. PMID: 22810696.
      51. Weinstein JN. Drug discovery: Cell lines battle cancer. Nature 483(7391):544-5, 2012. e-Pub 2012. PMID: 22460893.
      52. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1. Science 333(6046):1154-7, 2011. e-Pub 2011. PMID: 21798897.
      53. Weinstein JN. A postgenomic visual icon. Science 319(5871):1772-3, 2008. e-Pub 2008. PMID: 18369130.
      54. Weinstein JN, Leitz FB. Electric Power from Differences in Salinity: The Dialytic Battery. Science 191(4227):557-559, 1976. e-Pub 1976. PMID: 17792805.

      Book Chapters

      1. Weinstein, JN. Cancer Bioinformatics. In: Cancer Medicine. 10th Edition. John Wiley, 2023.
      2. Weinstein JN, Ralston E, Leserman LD, Klausner RD, Dragsten P, Blumenthal R. Self-quenching of carboxyfluorescein Fluorescence: Uses in studying lioposome stability and liposome-cell interaction. In: Liposome Technology. CRC Press, 183-204, 2018.
      3. Weinstein JN. Cancer Bioinformatics. In: Cancer Medicine, 9th Edition. John Wiley, 2017.
      4. Ben-Dor A, Lipson D, Tsalenko A, Baumbusch L, Barrett MM, Weinstein JN, Reimers M, A-L B, Yakhini Z. Framework for Identifying Common Aberrations in DNA Copy Number Data. In: RECOMB 2007. Springer Berlin, 122-36, 2007.
      5. Weinstein JN. Linking drugs and genes: Pharmacogenomics, pharmacoproteomics, bioinformatics, and the NCI-60. In: Oncogenomics: Molecular Approaches to Cancer. John Wiley & Sons, 117-37, 2004.
      6. Viswanadhan VN, Ghose AK, Kiselyov A, Weinstein JN, Wendeloski JJ. Knowledge-based approaches for the design of small molecule libraries for drug discovery. In: Combinatorial library design and evaluation: Principles, software tools, and Applications in Drug Discovery. Marcel-Dekker, 8888, 2001.
      7. Weinstein JN, Waltham M, Reinhold W, Lee JK, Smith LH, Andrews D, Tanabe L, Zhou Y, Myers TG, Buolamwini JK, Scherf U. The current revolution in cancer drug discovery: Genomics, proteomics, and bioinformatics. In: Fighting against Cancer: Progress and New Hopes, 21-36, 2000.
      8. Casciari J, Sato H, Durum, SK, Fiege J, Weinstein JN. Tabular lexicon of cytokine structure and function. In: Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott-Raven, 787-810, 1996.
      9. Casciari J, Sato H, Durum SK, Fiege J, Weinstein JN. Reference databases of cytokine structure and function. In: Chemotherapy and Biological Response Modifiers Annual 16. Elsevier, 315-46, 1996.
      10. Chabner BA, Weinstein JN, Paull KD, Grever MR. Cell line-based screening for new anticancer drugs. In: Cancer Treatment an Update. Springer-Verlag France, 10-6, 1994.
      11. Weinstein JN. Neural networks and predictive statistics in drug discovery. In: Handbook for the International Forum on Advances in Screening Technology and Data Management, 79-83, 1994.
      12. Weinstein JN, Bunow, B. COMBO: New concepts and methods for designing and analyzing experiments on combination therapy. In: Combination Therapies: Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases. Plenum Press, 29-38, 1992.
      13. Weinstein JN, Fujimore K. Antibody-mediated drug delivery. In: Protein Design and the Development of New Therapeutics and Vaccines. Plenum Press, 359-70, 1990.
      14. Weinstein JN, Fujimori K. The pharmacokinetics of monoclonal antibodies and derived peptides. In: Preclinical Evaluation of Peptides and Recombinant Proteins. Skogs Grafiska AB, 35-41, 1990.
      15. Weinstein JN, Fujimori K. Predictive Pharmacology of monoclonal antibodies. In: Cancer Therapy: New Trends. Springer-Verlag, 197-9, 1989.
      16. Weinstein JN. Immunolymphoscintigraphy and other regional applications of monoclonal antibodies. In: Antibodies in Radiodiagnosis and Therapy. CRC Press, 153-67, 1988.
      17. Weinstein JN, Black CDV, Holton III OD, Covell DG, Parker RJ, Mulshine JL, Lotze MT, Carrasquillo J, Eger RR, Lewis A, Sm L, Keenan AM. Delivery of monoclonal antibodies to lymph nodes via the lymphatics. In: The Pharmacology and Toxicology of Proteins. Alar R. Liss, 75-89, 1987.
      18. Weinstein JN. Liposomes in the diagnosis and treatment of cancer. In: Liposomes. Marcel Dekker, 277-338, 1987.
      19. Weinstein JN, Covell DG, Barbet J, Eger RR, Holton III OD, Talley MJ, Parker RJ, black CDV. The pharmacology of monoclonal antibodies. In: Membrane-mediated Cytotoxicity. Alan R. Liss, 279-89, 1987.
      20. Weinstein JN, Blumenthal R, Klausner RD. Carboxyfluorescein leakage assay for lipoprotein-liposome interaction. In: Methods in Enzymol. A. Academic Press, 657-68, 1986.
      21. Weinstein JN, Leserman LD. Liposomes as drug carriers in cancer chemotherapy. In: The International Encyclopedia of Pharmacology and Therapeutics: Membrane Transport of Anti-neoplastic Agents. Pergamon Press, 169-94, 1986.
      22. Weinstein JN, Black CDV, Keenan AM, Holton III OD, Larson SM, Sieber SM, Covell DG, Carrasquillo J, Barbet J, Parker RJ. Use of monoclonal antibodies for detection of lymph node metastases. In: Monoclonal Antibodies in Cancer Therapy. Alan R. Liss, 473-88, 1986.
      23. Weinstein JN, Black CDV, Barbet J, Eger RR, Parker RJ, Holton III OD, Mulshine JL, Keenan AM, Larson SM, Carrasquillo JA, Sieber SM, Covell DG. Selected issues in the pharmacology of monoclonal antibodies. In: Site-specific Drug Delivery: Cell Biology, Medicinal and Pharmaceutical Aspects. John Wiley, 81-91, 1986.
      24. Weinstein JN, Keenan AM, Holton III OD, Covell DG, Sieber SM, Black CDV, Barbet J, Parker RJ. Use of monoclonal antibodies to detect metastases of solid tumors in lumph nodes. In: Monoclonal Antibodies and Breast Cancer. Martinus Nijhof, 218-32, 1985.
      25. Weinstein JN, Holton OD, Black CDV, Keenan AM, Covell DG, Spaulding GF, Barbet J, Steller MA, Sieber SM, Talley MJ, Parker RJ. Monoclonal Antitumor antibodies in the lumphatics. In: 1985 Year Book of Cancer. Year Book Medical Publishers, 264-6, 1985.
      26. Blumenthal R, Kempf C, Renswoude JV, Weinstein JN, Klausner RD. Voltage-dependent orientation of membrane proteins. In: Protein Transport and Secretion. Alan R. Liss, 1-13, 1984.
      27. Weinstein JN, Leserman LD, Henkart PA, Blumental R. Antibody-mediated targeting of liposomes. In: Targeting of Drugs. Plenum, 185-202, 1982.
      28. Magin RL, Weinstein JN. Delivery of drugs in temperature-sensitive liposomes. In: Targeting of Drugs. Plenum, 203-21, 1982.
      29. Magin RL, Weinstein JN. Selective delivery of drugs in "temperature-sensitive" liposomes. In: Liposomes and Immunobiology. Elsevier, 315-25, 1980.
      30. Leserman LD, Weinstein JN. Receptor mediated binding and endocytosis of drug-containing liposomes by tumor cells. In: Liposomes and Immunobiology. Elsevier, 241-51, 1980.
      31. Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. Use of hyperthermia to promote selective local release of drugs from liposomes. In: Proceedings of the Conference on Clinical Prospects for Hypoxic Cell Sensitizers and Hyperthermia. Madison Printing and Publishing Company, 105-12, 1978.

      Patents

      1. Treatment of Diagnosis by Endoscopic Administration into the Lymphatics. Patent Number: 9999.
      2. Therapeutic Asparaginases. Patent Number: 14/917,934.
      3. Materials and Methods Directed to Asparagine Synthetase and Asparaginease Therapies. Patent Number: Patent #9181552.
      4. Restriction Display (RD-PCR) of Differentially Expressed mRNAs. Patent Number: 9999.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 04, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top